BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc.: A large extent of new developments in the neurovascular devices market stems from strides made in endovascular treatment.

NeoImmuneTech, Inc., a T cell-focused therapeutics company, announced that the U.S. Food and Drug Administration has granted NT-I7 Orphan Drug Designation for the treatment of Glioblastoma Multiforme.

Alliance Pharma, a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, closed on the purchase of Drug Development Solutions, a U.K.-based bioanalytical and material science testing contract research organization, from LGC.

Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult to treat cancers, announced that the Company will report second quarter 2022 financial results on Thursday, July, 21, 2022, after market close.